• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>InterCept

InterCept

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Global Cirrhosis Therapeutics Pipeline Review 2014 - 7 Companies & 8 Drug Profiles

    Research and Markets: Global Cirrhosis Therapeutics Pipeline Review 2014 - 7 Companies & 8 Drug Profiles

  2. Is ApplePay vulnerable to an iHack?

    Is ApplePay vulnerable to an iHack?

  3. Roxgold Reports Financial Results For Second Quarter 2014

    Roxgold Reports Financial Results For Second Quarter 2014

  4. More encouraging results from IVR project near Meadowbank; additional drill rigs and new exploration camp mobilized

    More encouraging results from IVR project near Meadowbank; additional drill rigs and new exploration camp mobilized

  5. Fitch Affirms Tennessee State School Bond Authority Ser 2010 QSCBs 'AA'; Outlook Stable

    Fitch Affirms Tennessee State School Bond Authority Ser 2010 QSCBs 'AA'; Outlook Stable

  6. Little-known ways hackers take over your phone, data and money

    Little-known ways hackers take over your phone, data and money

  7. Shrinking Alpha

    Common sources of return can now explain performance that was once attributed to skill.

  8. Understanding Factor Models

    A primer on how linear factor models are used to look at fund manager performance. 

  9. Optimal Portfolios for the Long Run

    Our study shows that equity risk declines as time horizon expands.

  10. The Predictive Power of Fair Value Estimates

    Investors would be smart to focus on stocks that trade at a discount to this metric.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.